Bimal R. Shah - Jun 13, 2024 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ Bimal R. Shah
Stock symbol
ANEB
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/17/2024, 04:23 PM
Previous filing
Oct 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +41.7K $0.00 41.7K Jun 13, 2024 Common Stock 41.7K $2.10 Direct F1
transaction ANEB Stock Option (right to buy) Award $0 +3.31K $0.00 3.31K Jun 13, 2024 Common Stock 3.31K $2.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant
F2 These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders